![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
By 2026, Pharma Contract Manufacturing To Be Worth $130bn
The global pharmaceutical contract manufacturing market is anticipated to reach $130.2 billion by 2026 as...
Leanings In The Biopharma Contract Manufacturing For 2022
A recent survey found that 86.9% of biopharmaceutical businesses outsource at least a portion of...
FTC Aims Manufacturer, PBM Rebates For Rising Insulin Costs
Bribes and rebate arrangements involving drugmakers and pharma middlemen are all being investigated by US...
Pfizer Commits $120mn In COVID-19 U.S. Oral Drug Production
COVID-19's propensity to fuel domestic drug production hasn't waned two years into the pandemic. Take,...
RCPE and InSilicoTrials to Digitalize and Accelerate the Development of Pharmaceutical Manufacturing Processes
RCPE and InSilicoTrials have agreed to an exclusive partnership to commercialize the XPS simulation software....
PIPAc Collaboration Enables New Compact, Mobile and Frugal Approach to Active Pharmaceutical Ingredient (API)...
The companies NovAliX, Alysophil, De Dietrich Process Systems and Bruker have joined forces to bring...
Catalent Invests $175 Million In A New Factory Expansion
Catalent, a manufacturing behemoth, has announced another expansion, this time at a large oral medication plant...
PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England
PCI Pharma Services is pleased to announce a major expansion of capabilities and capacity in...
Lonza and ALSA Ventures Collaborate to Provide Development and Manufacturing Services for Biotech Firms
Lonza and ALSA Ventures Colloboration: ALSA Ventures, a London based European biotech investment firm, and...
Astorg to acquire leading Pharmaceutical Contract Development & Manufacturing Organization CordenPharma from ICIG
Astorg and International Chemical Investors Group announce that they have signed a binding agreement whereby...